Search for Clinical Trial Results
Acute-On-Chronic Liver Failure - 42 Studies Found
Status | Study |
Terminated |
Study Name: Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units Condition: Acute on Chronic Hepatic Failure Date: 2010-03-01 Interventions:
|
Recruiting |
Study Name: Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study Condition: Liver Cirrhosis With Acute Decompensation Date: 2017-02-13 Interventions: Other: Observation protocol The whole cohort will be followed for 3 months, while Group 1 will be follow |
Recruiting |
Study Name: Predictive Utility of DASIMAR as a Prognostic Biomarker in Acute-on-chronic Liver Failure (ACLF) Condition: Liver Cirrhosis Date: 2010-02-18 |
Recruiting |
Study Name: Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver Disease Condition:
Date: 2015-07-25 Interventions: Other: Acute deterioration of liver function development of new ascites within 4 weeks or re-emergence o |
Recruiting |
Study Name: Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure Condition: Acute on Chronic Hepatic Failure Date: 2016-03-08 Interventions:
|
Recruiting |
Study Name: To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF). Condition: Acute-On-Chronic Liver Failure Date: 2017-04-20 Interventions:
|
Recruiting |
Study Name: To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis. Condition: Cirrhosis Date: 2015-06-04 |
Completed |
Study Name: Elimination of Albumin-Bound Substances by MARS and Prometheus Condition: Liver Failure Date: 2006-12-01 Interventions:
|
Completed |
Study Name: Prognosis Scoring System for Acute-on-Chronic Liver Failure Condition: Liver Failure Date: 2013-10-09 |
Not yet recruiting |
Study Name: The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF. Condition: Liver Failure Date: 2017-02-23 Interventions: Drug: Thymosin-α1 1.6 mg s.c injection once per day for 7 days, then 1.6 mg s.c injection twice a w |